Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record’s latest update dates changed from July 30–31, 2026, to November 11–12, 2026.
    Difference
    0.1%
    Check dated 2026-11-14T13:49:58.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The NIH transition announcement about updated terminology and related FAQs was removed from the top of the page.
    Difference
    1%
    Check dated 2026-11-07T13:24:02.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0. The study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:02:11.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A banner announces updates to NIH websites and says some NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-24T14:46:12.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:39:17.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:38:53.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.